Latest Kidney Cancer News

Transcriptomic characterization and innovative molecular classification of clear cell renal cell carcinoma in the Chinese population

Prognostic role of smoking in metastatic renal cell carcinoma in real-world data from the Turkish Oncology Group Kidney Cancer Consortium (TKCC) – Scientific Reports

Thermal Ablation vs Surgery for Stage T1a RCC Offers Similar Cancer-Specific Survival – Oncology Nurse Advisor
Kidney Cancer News elsewhere on the Web

Positive drug recommendation from NICE, enabled by collaboration between NHS England and MSD, accessed through the Cancer Drugs Fund.

Cody Bass was diagnosed with metastatic kidney cancer when he was 17. Two years later, he has no evidence of disease, thanks to a clinical trial at MSK.

Emre Yekedüz, MD, discusses a case study shared via social media that evaluated treatment options for a patient with clear cell renal cell carcinoma.

Fianlimab plus cemiplimab was well-tolerated and showed durable responses, in pretreated patients with advanced clear cell renal carcinoma.

“Our study highlights critical gaps in health care equity when it comes to treatments that have been shown effective in prolonging survival,” says Solomon Woldu, MD.

Medical experts give an overview of renal cell carcinoma (RCC), detailing the differences between clear cell and non–clear cell subtypes, the various forms of non–clear cell RCC, and the demographic and risk factor profiles associated with each subtype, while also discussing how histological ...

Rashad Nawfal, MD, discusses the association between radiologic tumor burden and OS in patients with metastatic ccRCC who had received frontline IO.

Background: This study aimed to investigate the effect of cytoreductive nephrectomy (CN) on the survival outcomes of nivolumab used as a subsequent therapy after the failure of at least one anti-vascular endothelial growth factor (VEGF) agent in patients with metastatic clear-cell renal-cell ...

Researchers have developed 3D-printed 'mini tumours' that behave like real cancerous tissue and can be used to test new immunotherapies.

Dr. Laurence Albiges, MD, PhD, reviews the recent findings presented at the American Society of Clinical Oncology (ASCO) 2024 meeting, specifically focusing on the results of the phase 3 STELLAR trial.
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.





